Market Research Logo

Global Extra Corporeal Membrane Oxygenation (ECMO) Market - Segmented by Application and Modality - Growth, Trends and Forecasts (2018 - 2023)

Global Extra Corporeal Membrane Oxygenation (ECMO) Market - Segmented by Application and Modality - Growth, Trends and Forecasts (2018 - 2023)

Extra corporeal membrane oxygenation market is for the patient that are suffering from both the heart failure and lung failure which acts as a cardiac and respiratory support. An ECMO machine works as a bypass for the heart and lungs which purifies the blood outside the human body. The global extra corporeal membrane oxygenation market is expected to register a CAGR of 3.6% during the forecast period, 2018 to 2023. North America dominates the market due to the favorable reimbursement scenario and rising incidence of lung cancer in that region.

Increasing incidences of cardiac disorders

Cardiovascular disease are the important cause of the death globally and many people die annually from the cardiovascular diseases than any other cause. According to the WHO 17.7 million people died from the cardiovascular disease which is around 31% of all global deaths and 7.4 million were due to coronary heart disease. These cardiovascular disease are rising due to the unhealthy diet, physical inactivity, tobacco use and excess use of alcohol.

In addition, technological advancement, rising incidence of the chronic obtrusive pulmonary disease (COPD) and increasing number of the cardiac surgeries are fuelling the growth of Global ECMO System Market.

Risk Associated with ECMO Treatment

The ECMO procedure is used to assist the transition from the cardiopulmonary bypass ventilation after heart surgery. There are many risks associated with ECMO machine which are bleeding with the skull and the risk of bleeding is increased if a surgical operation is required as the part of the treatment. Stroke, arteries or veins are being damaged during the ECMO procedure and infection.

In addition, high cost of the ECMO procedure restrict it to be available to some patient which can afford it and presence of alternative techniques other than ECMO are hindering the growth of Global ECMO system Market.

North America to Dominate the Market

The Global ECMO System market is segmented by application of ECMO in various filed such as Cardiac, Respiratory and Extracorporeal Cardiopulmonary Resuscitation. Further, it is also segmented by the type of modality such as Veno-Arterial, Veno-Venous and Arterio-Venous. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America. North America dominates the market due to the favorable reimbursement scenario and rising incidence of lung cancer in that region.

Key Developments in the market

  • October, 2017: LivaNova Receives FDA Approvals for SenTiva Device and Next-Generation Vagus Nerve Stimulation (VNS) Therapy Programming System for Treatment of Epilepsy.
  • July, 2017: Castor Branched Aortic Stent-Graft System receives approval from China Food and Drug Administration (CFDA) on 11 July 2017.
Key Players: MEDTRONIC, INC., NIPRO, TERUMO CARDIOVASCULAR SYSTEM CORPORATION, ALUNG TECHNOLOGIES INC, LIVANOVA PLC and MICROPORT SCIENTIFIC CORPORATION

Reasons to purchase this report
  • Current and future Global ECMO System Market outlook in the developed and emerging markets
  • Analyzing various perspectives of the market with the help of Porter’s five forces analysis
  • The treatment type that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identify the latest developments, market shares and strategies employed by the major market players.
  • 3 months analyst support along with the Market Estimate sheet in excel.
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1. INTRODUCTION
1.1 MARKET DEFINITION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW
5.1 CURRENT MARKET SCENARIO
5.2 PORTER’S FIVE FORCES
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF CONSUMERS
5.2.3 THREATS OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTE PRODUCT AND SERVICES
5.2.5 COMPETITIVE RIVALRY WITHIN THE INDUSTRY
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 MARKET DRIVERS
6.1.1 INCREASING INCIDENCES OF CARDIAC DISORDERS
6.1.2 TECHNOLOGICAL ADVANCEMENT
6.2 MARKET RESTRAINTS
6.2.1 RISK ASSOCIATED WITH ECMO TREATMENT
6.2.2 HIGH COST OF THE ECMO PROCEDURE
6.3 OPPORTUNITIES
6.4 KEY CHALLENGES
7. MARKET SEGMENTATION
7.1 BY APPLICATION
7.1.1 CARDIAC
7.1.2 RESPIRATORY
7.1.3 EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
7.2 BY MODALITY
7.2.1 VENO-ARTERIAL
7.2.2 VENO-VENOUS
7.2.3 ARTERIO-VENOUS
7.3 BY GEOGRAPHY
7.3.1 NORTH AMERICA
7.3.1.1 US
7.3.1.2 CANADA
7.3.1.3 MEXICO
7.3.2 EUROPE
7.3.2.1 FRANCE
7.3.2.2 UK
7.3.2.3 GERMANY
7.3.2.4 ITALY
7.3.2.5 SPAIN
7.3.2.6 REST OF EUROPE
7.3.3 ASIA-PACIFIC
7.3.3.1 INDIA
7.3.3.2 CHINA
7.3.3.3 JAPAN
7.3.3.4 AUSTRALIA
7.3.3.5 SOUTH KOREA
7.3.3.6 REST OF APAC
7.3.4 MIDDLE EAST AND AFRICA
7.3.4.1 GCC
7.3.4.2 SOUTH AFRICA
7.3.4.3 REST OF MIDDLE EAST AND AFRICA
7.3.5 SOUTH AMERICA
7.3.5.1 BRAZIL
7.3.5.2 ARGENTINA
7.3.5.3 REST OF SOUTH AMERICA
8. COMPETITIVE LANDSCAPE
8.1 MERGERS AND ACQUISITIONS
8.2 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS
8.3 NEW PRODUCT LAUNCHES
9. KEY PLAYERS
9.1 MEDTRONIC
9.2 NIPRO
9.3 ALUNG TECHNOLOGIES INC
9.4 TERUMO
9.5 MICROPORT SCIENTIFIC CORPORATION
9.6 LIVANOVA PLC
9.7 OTHERS
10. FUTURE OUTLOOK OF THE MARKET

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report